Loading...
FRESENIUS KABI USA, LLC — Syringe Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #1 buyer for Syringe · $15.5M import value · 341 shipments · UNITED STATES · DGFT Verified
FRESENIUS KABI USA, LLC is the #1 importer of Syringe from India with $15.5M in import value and 341 verified shipments. FRESENIUS KABI USA, LLC holds a 9.5% market share in Syringe imports based in UNITED STATES. The company sources from 1 verified supplier across 38 formulations shipped to 1 country. Overall, FRESENIUS KABI USA, LLC imports 6 pharmaceutical products worth $71.2M across 5 therapeutic categories.
Verified from 341 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $15.5M | 341 | 100.0% |
FRESENIUS KABI USA, LLC sources Syringe from 1 verified Indian supplier based on 341 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLC ★ | UNITED STATES | $17.1M | 341 | $50.0K |
| 2 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $4.8M | 95 | $50.0K |
| 3 | BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $4.8M | 95 | $50.0K |
FRESENIUS KABI USA, LLC ranks #1 among 751 Syringe importers from India. Average shipment value of $50.0K compared to the market average of $57.6K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and BOSTON ONCOLOGY ARABIA.
Destination countries from 341 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $15.5M | 341 | 100.0% |
FRESENIUS KABI USA, LLC imports Syringe to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $15.5M.
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGE | $6.3M | 137 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG in 0.4ml PRE-FILLED SYRINGES | $1.7M | 43 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $1.3M | 28 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 30MG IN 0.3ML PREFILLED SYRINGE | $982.8K | 23 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGENOS | $777.4K | 18 |
| (LOW MOLECULAR WEIGHTHEPARIN) ENOXAPARINSODIUM INJECTION USP,40MG IN 0.4ML PRE-FILLEDSYRINGES | $700.0K | 14 |
| (LOW MOLECULAR WEIGHTHEPARIN) ENOXAPARINSODIUM INJECTION USP,40MG PRE-FILLEDSYRINGES | $600.0K | 12 |
| LOW MOLECULAR WEIGHTHEPARIN ENOXAPARINSODIUM INJECTION USP,30MG IN 0.3ML PREFILLED SYRINGE |
What FRESENIUS KABI USA, LLC and other importers must comply with to import Syringe from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $43.3M worth of Syringe through 3,522 shipments from 291 suppliers to 154 countries, serving 751 buyers globally. FRESENIUS KABI USA, LLC imports $15.5M of this total, accounting for 9.5% of India's Syringe exports with 341 shipments from UNITED STATES. This is verified from 341 customs shipment records covering 38 distinct formulations.
FRESENIUS KABI USA, LLC's average Syringe order value is $45.5K per consignment, based on 341 shipments totaling $15.5M. FRESENIUS KABI USA, LLC is based in UNITED STATES and ranks #1 among all Syringe importers from India by value. The company sources from 1 verified supplier in India.
FRESENIUS KABI USA, LLC sources Syringe from 1 verified Indian supplier: GLAND PHARMA LIMITED ($15.5M, 100.0%). This is based on 341 customs records.
FRESENIUS KABI USA, LLC ranks #1 among 751 Syringe importers from India with a 9.5% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($17.1M), YUSEN LOGISTICS BENELUX BELGIUM ($4.8M), BOSTON ONCOLOGY ARABIA ($4.8M). FRESENIUS KABI USA, LLC processed 341 shipments from UNITED STATES.
FRESENIUS KABI USA, LLC imports 6 products worth $71.2M. Beyond Syringe, top products include Enoxaparin, Heparin, Sodium, Acyclovir, Voriconazole. View the complete FRESENIUS KABI USA, LLC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Syringe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI USA, LLC's Syringe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI USA, LLC
Full Company Profile →
6 products · $71.2M total trade · 5 categories
| $450.0K |
| 9 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 60MG IN 0.6ML PREFILLED SYRINGE | $447.7K | 10 |
| LOW MOLECULAR WEIGHTHEPARIN ENOXAPARINSODIUM INJECTION USP,60MG IN 0.6ML PRE-FILLEDSYRINGE | $196.0K | 4 |
FRESENIUS KABI USA, LLC imports 38 distinct Syringe formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, with 137 shipments worth $6.3M.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 751+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI USA, LLC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Syringe. For current order-level data, contact TransData Nexus.